FI951155A0 - Farmaceutiskt preparat - Google Patents
Farmaceutiskt preparatInfo
- Publication number
- FI951155A0 FI951155A0 FI951155A FI951155A FI951155A0 FI 951155 A0 FI951155 A0 FI 951155A0 FI 951155 A FI951155 A FI 951155A FI 951155 A FI951155 A FI 951155A FI 951155 A0 FI951155 A0 FI 951155A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9404928A GB2287880A (en) | 1994-03-14 | 1994-03-14 | Production of sustained release compositions |
GB9411842A GB9411842D0 (en) | 1994-06-14 | 1994-06-14 | Pharmaceutical preparation |
EP94308493A EP0654263B1 (en) | 1993-11-23 | 1994-11-17 | Method for preparing a sustained release composition |
GB9423498A GB9423498D0 (en) | 1994-11-21 | 1994-11-21 | Pharmaceutical preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
FI951155A0 true FI951155A0 (sv) | 1995-03-13 |
FI951155A FI951155A (sv) | 1995-09-15 |
Family
ID=27442925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI951155A FI951155A (sv) | 1994-03-14 | 1995-03-13 | Farmaceutiskt preparat |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0672416A1 (sv) |
JP (1) | JPH0840905A (sv) |
AU (1) | AU694475B2 (sv) |
CA (1) | CA2144500A1 (sv) |
FI (1) | FI951155A (sv) |
NO (1) | NO950950L (sv) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
GB9614902D0 (en) * | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
DE19729487A1 (de) * | 1997-07-10 | 1999-01-14 | Dresden Arzneimittel | Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix |
CA2328154A1 (en) * | 1998-04-17 | 1999-10-28 | Taisho Pharmaceutical Co., Ltd. | Multiple-unit sustained release tablets |
DE19923551A1 (de) * | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
EP1551402A4 (en) * | 2002-09-23 | 2009-05-27 | Verion Inc | PHARMACEUTICAL COMPOSITIONS NOT INDUCING ABUSE |
GB2403711A (en) * | 2003-07-07 | 2005-01-12 | Gw Pharma Ltd | Drug dispenser with controlled access |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
SE9003296L (sv) * | 1990-10-16 | 1992-04-17 | Kabi Pharmacia Ab | Foerfarande foer att formulera laekemedel |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
SE9200858L (sv) * | 1992-03-20 | 1993-09-21 | Kabi Pharmacia Ab | Metod för framställning av pellets med fördröjd frisättning |
-
1995
- 1995-03-02 EP EP95301337A patent/EP0672416A1/en not_active Withdrawn
- 1995-03-13 AU AU14755/95A patent/AU694475B2/en not_active Ceased
- 1995-03-13 FI FI951155A patent/FI951155A/sv unknown
- 1995-03-13 CA CA002144500A patent/CA2144500A1/en not_active Abandoned
- 1995-03-13 NO NO950950A patent/NO950950L/no unknown
- 1995-03-13 JP JP7052498A patent/JPH0840905A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO950950L (no) | 1995-09-15 |
AU1475595A (en) | 1995-09-21 |
JPH0840905A (ja) | 1996-02-13 |
FI951155A (sv) | 1995-09-15 |
AU694475B2 (en) | 1998-07-23 |
EP0672416A1 (en) | 1995-09-20 |
NO950950D0 (no) | 1995-03-13 |
CA2144500A1 (en) | 1995-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0783302T3 (da) | Lægemidler | |
NO20004345L (no) | Farmasøytisk sammensetning | |
BR9610153A (pt) | Formulações farmacêuticas | |
BR9611626A (pt) | Formulações farmacéuticas | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
BR9508339A (pt) | Medicamento | |
BR9507768A (pt) | Composição farmacêutica | |
LV11727A (lv) | Farmaceitiska kompozicija | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
FI973280A0 (sv) | Farmaceutisk komposition | |
FI951155A0 (sv) | Farmaceutiskt preparat | |
FI973230A (sv) | Ny farmaceutisk formulation | |
FI962738A (sv) | Farmaceutiska sammansättningar | |
DE69503368D1 (de) | Dermatologisches präparat | |
BR9605777A (pt) | Composição farmacêutica | |
NO964309D0 (no) | Farmasöytisk sammensetning | |
SE9402924D0 (sv) | Novel pharmaceutical composition | |
ATA77096A (de) | Pharmazeutische präparation | |
SE9302429D0 (sv) | New pharmaceutical preparation ii | |
FI3862U1 (sv) | Gelformigt farmaceutiskt preparat | |
NO944330D0 (no) | Legemiddel | |
SE9402131D0 (sv) | Läkemedel | |
SE9401674L (sv) | Läkemedel | |
SE9404195D0 (sv) | New pharmaceutical formulation |